Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)

Hong Kong · Delayed Price · Currency is HKD

8.81

+0.01 (0.11%)

Jun 18, 2026, 4:08 PM HKT

-26.21% (1Y)

Market Cap	5.88B -7.9%
Revenue (ttm)	1.17B +26.9%
Net Income	313.93M +116.0%
EPS	0.82 +112.3%
Shares Out	382.19M
PE Ratio	10.76
Forward PE	8.55
Dividend	0.42 (4.74%)
Ex-Dividend Date	May 28, 2026

Volume	851,200
Open	8.70
Previous Close	8.80
Day's Range	8.60 - 8.89
52-Week Range	8.60 - 20.82
Beta	-0.24
Analysts	Strong Buy
Price Target	20.44 (+132.01%)
Earnings Date	Aug 28, 2026

About HKG:1858

Beijing Chunlizhengda Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally. The company offers orthopedic medical devices and tissue repair products, including spine, trauma, joint, sports medicine, and bone repair material implants; surgical instrumentation products; platelet-rich plasma preparation kits; and closed wound negative pressure drainage kits. It also provi... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 1,078

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1858

Full Company Profile

Financial Performance

In 2025, HKG:1858's revenue was 1.05 billion, an increase of 29.77% compared to the previous year's 805.86 million. Earnings were 272.54 million, an increase of 118.05%.

Financial numbers in CNY Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 1858 stock is "Strong Buy." The 12-month stock price target is $20.44, which is an increase of 132.01% from the latest price.

Price Target

$20.44

(132.01% upside)

Analyst Consensus: Strong Buy

Stock Forecasts